[HTML][HTML] The interaction of hepatic lipid and glucose metabolism in liver diseases

LP Bechmann, RA Hannivoort, G Gerken… - Journal of …, 2012 - Elsevier
It is widely known that the liver is a central organ in lipogenesis, gluconeogenesis and
cholesterol metabolism. However, over the last decades, a variety of pathological conditions …

Therapeutic potential of PPARγ natural agonists in liver diseases

L Wu, C Guo, J Wu - Journal of cellular and molecular …, 2020 - Wiley Online Library
Peroxisome proliferator‐activated receptor gamma (PPARγ) is a vital subtype of the PPAR
family. The biological functions are complex and diverse. PPARγ plays a significant role in …

Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of …

AM Mahmoud, HM Mohammed, SM Khadrawy… - Chemico-Biological …, 2017 - Elsevier
Hesperidin is a plant-derived bioflavonoid with promising antitumor efficacy, though the
underlying mechanisms of action remain poorly elucidated. Thus, we evaluated the in vivo …

Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways

L Yu, M Wang, Y Yang, F Xu, X Zhang… - PLoS Computational …, 2021 - journals.plos.org
Hepatocellular carcinoma (HCC) is a significant health problem worldwide with poor
prognosis. Drug repositioning represents a profitable strategy to accelerate drug discovery …

Influence of liver cancer on lipid and lipoprotein metabolism

J Jiang, P Nilsson-Ehle, N Xu - Lipids in health and disease, 2006 - Springer
Liver plays a key role in the metabolism of plasma apolipoproteins, endogenous lipids and
lipoproteins. Hepatocellular carcinoma (HCC) is one of the most common fatal malignant …

MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma

Z Liu, Y Wang, C Dou, L Sun, Q Li, L Wang… - Journal of Experimental …, 2018 - Springer
Background Accumulating evidence confirm that aberrant microRNAs (miRNAs) expression
contributes to hepatocellular carcinoma (HCC) development and progression. Previous …

Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice

H Chen, W Cai, ESH Chu, J Tang, CC Wong, SH Wong… - Oncogene, 2017 - nature.com
Abstract Cyclooxygenase (COX)-2 is upregulated in hepatocellular carcinoma (HCC).
However, the direct causative effect of COX-2 in spontaneous HCC formation remains …

PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice

B Shen, ESH Chu, G Zhao, K Man, CW Wu… - British journal of …, 2012 - nature.com
Background: We have previously demonstrated that peroxisome proliferator-activated
receptor (PPARγ) activation inhibits hepatocarcinogenesis. We aim to investigate the effect …

Gene expression changes induced by PPAR gamma agonists in animal and human liver

A Rogue, C Spire, M Brun, N Claude… - PPAR …, 2010 - Wiley Online Library
Thiazolidinediones are a class of Peroxisome Proliferator Activated Receptor γ (PPARγ)
agonists that reduce insulin resistance in type 2 diabetic patients. Although no detectable …

Transcription factors: The fulcrum between cell development and carcinogenesis

Z Islam, AM Ali, A Naik, M Eldaw, J Decock… - Frontiers in …, 2021 - frontiersin.org
Higher eukaryotic development is a complex and tightly regulated process, whereby
transcription factors (TFs) play a key role in controlling the gene regulatory networks …